Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment
Triple-negative breast cancer (TNBC) is a highly aggressive type of breast cancer that encompasses several distinct subtypes. Recent advances in immunotherapy offer a promising future for the treatment of these highly heterogeneous and readily metastat…